ClinConnect ClinConnect Logo
Search / Trial NCT04355195

Quality Contract: Prevention of Postoperative Delirium in the Care of Older Patients (QV-POD-2)

Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Apr 17, 2020

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

ClinConnect Summary

The clinical trial titled "Quality Contract: Prevention of Postoperative Delirium in the Care of Older Patients" (QV-POD-2) is focused on improving care for older patients who are having surgery. The goal is to reduce the risk of delirium, a serious condition that can cause confusion and changes in behavior after surgery. To achieve this, the study will implement specific strategies that are based on research and expert agreement, ensuring that patients receive the best possible care before, during, and after their surgery. The trial will use electronic records to track symptoms and help healthcare providers respond quickly if a patient shows signs of delirium.

To be eligible for this trial, participants need to be at least 70 years old and insured with certain health insurance companies. Both men and women can take part, and those who cannot provide consent may have a legal representative do so on their behalf. Patients can expect to undergo evaluations of their heart function before surgery, which may help understand how heart health relates to the risk of developing delirium. Additionally, healthcare workers involved in the trial will provide feedback on the care process to help improve future practices.

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • Age ≥ 70 years
  • male and female patients
  • Patients who are insured with BARMER, HEK, KKH, DAK, TK or hkk Health insurances
  • Patients eligible for inclusion: by the patient, preoperatively
  • Incapacitated patients for inclusion: Written informed consent by a legal representative
  • surgery (elective and not elective)
  • Exclusion criteria:
  • Moribund patients
  • Not enough language skills

About Charite University, Berlin, Germany

Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.

Locations

Berlin, , Germany

Berlin, , Germany

Berlin, , Germany

Berlin, , Germany

Patients applied

0 patients applied

Trial Officials

Claudia Spies, MD, Prof.

Study Director

Charite University, Berlin, Germany

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials